ACO Name and Location

Health Point ACO, LLC
2055 Wood Street, Suite 100
Sarasota, Florida 34237

ACO Primary Contact

Primary Contact Name Neil Bedi, CEO
Primary Contact Phone Number 941-284-7264
Primary Contact Email Address nbedi@subserohealth.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Florida Medical Specialists, LLC. N

 

ACO governing body:

 

Member

Member’s Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

BLANKENSHIP THOMAS CHAIRMAN ACO Participant Representative Florida Medical Specialists, LLC
BEDI INITA SECRETARY ACO Participant Representative Florida Medical Specialists, LLC
MISHNER HARVEY DIRECTOR ACO Participant Representative Florida Medical Specialists, LLC
BRUNNER JOSEPH DIRECTOR Medicare Beneficiary Representative Florida Medical Specialists, LLC

Key ACO clinical and administrative leadership:

Neil Bedi ACO Executive
Jonathan Ware Medical Director
Neil Bedi Compliance Officer
Neil Bedi Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Compliance Committee Dr. Scott Clulow-Chairman
Quality Oversight Committee Dr. Daniela Kassabov-Chairman
ACO Participant Review Committee Dr. Werther Marciales-Chairman
Care Coordination Committee Dr. Shahnaz Ahmed-Chairman

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2017, $2,554,966
  • First Agreement Period
    • Performance Year 2016, $3,239,297
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/suppliers
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/suppliers
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2017 Quality Performance Results:

ACO#  Measure Name Rate  ACO   Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 80.36 80.60
ACO-2 CAHPS: How Well Your Providers Communicate 90.78 93.13
ACO-3 CAHPS: Patients’ Rating of Provider 89.31 92.31
ACO-4 CAHPS: Access to Specialists 81.37 83.32
ACO-5 CAHPS: Health Promotion and Education 64.42 62.30
ACO-6 CAHPS: Shared Decision Making 75.28 75.85
ACO-7 CAHPS: Health Status/Functional Status 76.08 73.05
ACO-34 CAHPS: Stewardship of Patient Resources 23.73 25.68
ACO-8 Risk Standardized, All Condition Readmission 15.71 15.01
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 19.77 18.46
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 60.60 53.95
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 80.83 79.16
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 61.55 61.74
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.97 1.93
ACO-11 Use of Certified EHR Technology 100.00 98.48
ACO-12 Medication Reconciliation 95.02 75.32
ACO-13 Falls: Screening for Future Fall Risk 85.15 74.38
ACO-44 Imaging Studies for Low Back Pain 69.23 67.32
ACO-14 Preventive Care and Screening: Influenza Immunization 85.83 72.52
ACO-15 Pneumonia Vaccination Status for Older Adults 87.60 72.92
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 90.19 70.69
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 96.41 90.48
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 69.11 61.98
ACO-19 Colorectal Cancer Screening 66.56 64.58
ACO-20 Breast Cancer Screening 76.67 70.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 86.33 79.89
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 10.92 16.74
ACO-41 Diabetes: Eye Exam 56.97 50.37
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 75.74 71.47
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 80.13 86.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Health Point ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A81718 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.